Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SINOPEC CORP
00386
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -82.59%-10.4B | ---- | -208.98%-5.7B | ---- | -371.38%-1.84B | ---- | -72.26%679.54M | ---- | -43.24%2.45B | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 54.47%-8.92M | ---- | 40.58%-19.6M | ---- | 49.59%-32.98M | ---- | 5.48%-65.43M | ---- | 39.22%-69.22M | ---- |
| Dividend (income)- adjustment | -12.96%-29.65M | ---- | -15.08%-26.25M | ---- | 0.00%-22.81M | ---- | -0.04%-22.81M | ---- | 0.00%-22.8M | ---- |
| Investment loss (gain) | ---- | ---- | ---- | ---- | ---- | ---- | ---12.61M | ---- | ---- | ---- |
| Attributable subsidiary (profit) loss | --2K | ---- | ---- | ---- | -50.00%1K | ---- | 0.00%2K | ---- | 0.00%2K | ---- |
| Impairment and provisions: | 278.50%3.85B | ---- | 33,948,633.33%1.02B | ---- | -99.99%3K | ---- | -47.17%36.39M | ---- | 69.57%68.87M | ---- |
| -Impairment of property, plant and equipment (reversal) | 477.82%3.85B | ---- | --667.12M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairment of trade receivables (reversal) | -99.54%23K | ---- | 166,233.33%4.99M | ---- | -99.99%3K | ---- | -47.17%36.39M | ---- | 69.57%68.87M | ---- |
| -Impairment of goodwill | ---- | ---- | --231.6M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | -99.91%107K | ---- | --114.75M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Revaluation surplus: | 90.44%5.51B | ---- | 163.32%2.9B | ---- | 153.72%1.1B | ---- | 22.80%-2.05B | ---- | -1,918.12%-2.65B | ---- |
| -Fair value of investment properties (increase) | 90.27%5.51B | ---- | 151.63%2.9B | ---- | 156.06%1.15B | ---- | 19.99%-2.05B | ---- | -1,172.79%-2.57B | ---- |
| -Derivative financial instruments fair value (increase) | ---- | ---- | 95.22%-2.49M | ---- | -807.49%-52.05M | ---- | 108.79%7.36M | ---- | 10.51%-83.67M | ---- |
| Asset sale loss (gain): | 5,564,375.00%222.58M | ---- | 300.00%4K | ---- | -108.70%-2K | ---- | 100.65%23K | ---- | 99.91%-3.56M | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 99.91%-3.57M | ---- |
| -Loss (gain) on sale of property, machinery and equipment | 670,825.00%26.84M | ---- | 300.00%4K | ---- | -108.70%-2K | ---- | 187.50%23K | ---- | -11.11%8K | ---- |
| -Loss (gain) from selling other assets | --195.74M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | -36.22%39.1M | ---- | 1.66%61.31M | ---- | -22.63%60.31M | ---- | 6.14%77.95M | ---- | 9.75%73.44M | ---- |
| -Depreciation | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 9.75%73.44M | ---- |
| Financial expense | -45.12%1.12B | ---- | 17.51%2.05B | ---- | -2.38%1.74B | ---- | 4.42%1.79B | ---- | 11.60%1.71B | ---- |
| Exchange Loss (gain) | 871.85%101.25M | ---- | 78.54%-13.12M | ---- | -295.86%-61.12M | ---- | 120.44%31.2M | ---- | 61.03%-152.64M | ---- |
| Special items | ---- | ---- | ---- | ---- | -104.45%-311K | ---- | --6.98M | ---- | ---- | ---- |
| Operating profit before the change of operating capital | 54.56%413.45M | ---- | -71.62%267.51M | ---- | 100.12%942.61M | ---- | -66.44%471.02M | ---- | -23.38%1.4B | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | -76.71%116K | ---- | 231.05%498K | ---- | -413.51%-380K | ---- | 28.16%-74K | ---- | -260.94%-103K | ---- |
| Developing property (increase)decrease | -48.44%-1.24B | ---- | 54.47%-836.93M | ---- | 71.58%-1.84B | ---- | -33.53%-6.47B | ---- | -955.10%-4.84B | ---- |
| Accounts receivable (increase)decrease | -873.23%-40.61M | ---- | -31.85%-4.17M | ---- | 94.70%-3.17M | ---- | -39.57%-59.74M | ---- | 42.83%-42.8M | ---- |
| Accounts payable increase (decrease) | 375.91%1.4B | ---- | -110.29%-505.69M | ---- | 41.52%4.91B | ---- | 3.44%3.47B | ---- | 139.01%3.36B | ---- |
| prepayments (increase)decrease | -97.76%15.87M | ---- | 108.27%708.45M | ---- | -294.60%-8.57B | ---- | -46.94%-2.17B | ---- | -319.73%-1.48B | ---- |
| Special items for working capital changes | -66.11%1.48B | ---- | 238.87%4.37B | ---- | -15.54%1.29B | ---- | 15,174.32%1.53B | ---- | 100.87%10.01M | ---- |
| Cash from business operations | -49.44%2.02B | ---- | 222.73%4B | ---- | -1.07%-3.26B | ---- | -102.48%-3.23B | ---- | -233.49%-1.59B | ---- |
| Other taxs | 88.47%-42.53M | ---- | -0.97%-368.99M | ---- | -19.93%-365.44M | ---- | 28.70%-304.71M | ---- | 37.82%-427.33M | ---- |
| Special items of business | ---- | 19.40%1.16B | ---- | 123.77%972.69M | ---- | -179.45%-4.09B | ---- | -105.68%-1.46B | ---- | -503.02%-711.87M |
| Net cash from operations | -45.48%1.98B | 19.40%1.16B | 200.20%3.63B | 123.77%972.69M | -2.70%-3.63B | -179.45%-4.09B | -74.75%-3.53B | -105.68%-1.46B | -498.73%-2.02B | -503.02%-711.87M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -46.95%13.78M | -91.81%2.79M | -7.25%25.98M | 24.81%34.06M | -64.38%28.01M | -26.10%27.29M | 62.47%78.62M | -16.32%36.93M | -51.48%48.39M | -4.45%44.12M |
| Dividend received - investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%22.8M | ---- |
| Loan receivable (increase) decrease | -156.56%-88.76M | -10,462.93%-316.89M | -0.69%156.94M | -100.17%-3M | 164.24%158.03M | 13,225.58%1.72B | -9,200.33%-245.98M | -106.65%-13.1M | 100.24%2.7M | 154.43%196.96M |
| Decrease in deposits (increase) | 147.60%2.05B | 1,376.00%1.08B | 155.49%827.87M | -50.80%73.49M | -192.18%-1.49B | -60.60%149.39M | 73.05%1.62B | -63.61%379.15M | 330.71%935.34M | 732.10%1.04B |
| Sale of fixed assets | 48,648.39%136.01M | --5K | 45.31%279K | ---- | --192K | ---- | ---- | ---- | 83.92%263K | ---- |
| Purchase of fixed assets | -421.21%-2.34M | -29.04%-702K | 79.10%-448K | 94.20%-544K | 32.34%-2.14M | -121.76%-9.38M | 70.72%-3.17M | -2.05%-4.23M | 31.02%-10.82M | 73.03%-4.14M |
| Purchase of intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -1,287.32%-36.88M |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --236K | ---- |
| Recovery of cash from investments | -74.38%219.09M | -97.56%18.91M | 261.92%855.01M | --775.11M | 427.16%236.24M | ---- | -16.17%44.81M | --11.45M | --53.46M | ---- |
| Cash on investment | -29.71%-1.02B | -2.94%-278.61M | 38.90%-785.95M | 38.26%-270.65M | 0.88%-1.29B | -121.24%-438.38M | -484.08%-1.3B | ---198.15M | ---222.19M | ---- |
| Other items in the investment business | 97.86%-54K | ---- | ---2.52M | ---- | ---- | ---- | ---- | ---- | ---- | -57.32%283K |
| Net cash from investment operations | 21.44%1.31B | -16.14%510.28M | 145.68%1.08B | -58.00%608.47M | -1,308.44%-2.36B | 583.17%1.45B | -76.50%195.13M | -82.93%212.05M | 158.79%830.18M | 2,220.35%1.24B |
| Net cash before financing | -30.18%3.29B | 5.72%1.67B | 178.72%4.71B | 159.82%1.58B | -79.35%-5.99B | -111.08%-2.64B | -180.16%-3.34B | -336.14%-1.25B | -31.59%-1.19B | 349.17%530.26M |
| Cash flow from financing activities | ||||||||||
| New borrowing | -78.90%1.63B | -94.37%227.5M | -59.85%7.7B | -65.29%4.04B | 32.81%19.18B | 179.03%11.64B | 32.91%14.45B | -2.12%4.17B | 64.60%10.87B | 16.78%4.26B |
| Refund | 61.59%-3.82B | 62.84%-1.51B | -11.30%-9.95B | 15.15%-4.06B | 17.97%-8.94B | -89.49%-4.79B | -29.82%-10.9B | 38.76%-2.53B | -97.76%-8.4B | -77.97%-4.13B |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -91.68%1.21M | 68.80%1.21M |
| Issuance of bonds | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -32.88%1.59B | ---- |
| Interest paid - financing | 32.75%-1.46B | 48.05%-646.43M | 29.75%-2.18B | 11.81%-1.24B | -34.86%-3.1B | -43.59%-1.41B | -10.10%-2.3B | -16.08%-982.61M | -17.50%-2.09B | -6.97%-846.5M |
| Dividends paid - financing | ---- | ---- | ---- | ---- | ---500K | ---- | ---- | ---- | 99.75%-696K | ---- |
| Absorb investment income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --165.43M |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | -196.10%-3.28B | -428.45%-3.17B | 47.52%-1.11B | ---599.31M | -4.79%-2.11B | ---- |
| Other items of the financing business | ---- | ---- | ---- | ---- | 0.00%1.14B | ---- | 586.48%1.14B | ---- | --165.43M | ---- |
| Net cash from financing operations | 16.74%-3.72B | -52.53%-1.96B | -189.71%-4.47B | -156.74%-1.28B | 296.11%4.98B | 4,002.80%2.26B | 7,108.65%1.26B | 109.95%55.08M | -97.34%17.43M | -126.87%-553.64M |
| Effect of rate | 109.98%13.55M | 7.74%29.14M | -80.58%-135.69M | 344.56%27.05M | -1,535.91%-75.14M | -171.68%-11.06M | 150.96%5.23M | 475.31%15.43M | 38.97%-10.27M | 46.14%-4.11M |
| Net Cash | -273.34%-427.81M | -195.04%-284.14M | 124.47%246.8M | 177.97%298.96M | 51.54%-1.01B | 67.97%-383.43M | -77.27%-2.08B | -5,020.28%-1.2B | -371.69%-1.17B | -101.07%-23.38M |
| Begining period cash | 22.85%597.46M | 22.85%597.46M | -69.02%486.35M | -69.02%486.35M | -56.94%1.57B | -56.94%1.57B | -24.52%3.65B | -24.52%3.65B | -5.21%4.83B | -5.21%4.83B |
| Cash at the end | -69.34%183.2M | -57.84%342.46M | 22.85%597.46M | -30.89%812.35M | -69.02%486.35M | -52.29%1.18B | -56.94%1.57B | -48.69%2.46B | -24.52%3.65B | -33.91%4.8B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Auditor | Bai Chun Accounting Firm Limited | -- | Bai Chun Accounting Firm Limited | -- | Deloitte Touche Tohmatsu会计师事务所 | -- | Deloitte Touche Tohmatsu会计师事务所 | -- | Deloitte Touche Tohmatsu会计师事务所 | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.